Teva Pharmaceuticals and Pain Management

At Teva Pharmaceuticals, we understand that chronic pain affects more than 100 million Americans.1 It can greatly affect people touching many aspects of their lives, including their physical health and ability to participate in daily tasks.1

Our Commitment to Pain Care

Teva is committed to supporting responsible pain management that meets the needs of people living with pain and healthcare professionals treating pain. With a diverse portfolio and pipeline, we are working to help advance treatments in pain management. Prescription opioid medications are an important part of a treatment plan for many people living with chronic pain, but we know that they carry a serious risk of abuse and misuse.2 Teva is equally committed to addressing the serious problems of chronic pain and prescription drug abuse.

As part of our ongoing commitment to support healthcare professionals and patients dealing with chronic pain, we are developing an innovative abuse deterrence technology platform to address the challenges of opioid abuse and misuse.

To learn more about Teva and our commitment, visit us online at TevaUSA.com

Community Collaboration

As a company, Teva takes this commitment beyond its products, leading education and abuse-mitigation efforts. We’re also working to develop educational resources and partner with a variety of stakeholders. In this complex pain care environment, Teva is focused on keeping patient needs at the center of all we do.

View Calendar

The Alliance to Prevent the Abuse of Medicines

In 2013, Teva became one of several leading industry stakeholders including the American Medical Association, CVS Caremark, Cardinal Health, the Healthcare Distribution Management Association, Prime Therapeutics, Millennium Health, and Kaleo dedicated to developing policy solutions aimed to address prescription drug abuse. This non-profit partnership includes perspectives from all angles of the prescription drug supply chain—from manufacturers to distributors and pharmacies to physicians.

Learn More